Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial.

Authors :: Onuma Y
Chevalier B
Ono M
Cequier À
Dudek D
Haude M
Carrié D
Sabaté M
Windecker S
Rapoza RR
West NEJ
Reith S
de Sousa Almeida M
Campo G
Íñiguez-Romo A
Serruys PW
Source :: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2020 Dec 04; Vol. 16 (11), pp. e938-e941. Date of Electronic Publication: 2020 Dec 04.
Publication Year :: 2020

Subjects :: Absorbable Implants
Everolimus
Humans
Prosthesis Design
Stents
Treatment Outcome
Coronary Artery Disease diagnostic imaging
Coronary Artery Disease surgery
Drug-Eluting Stents
Percutaneous Coronary Intervention adverse effects

Language :: English
ISSN :: 1969-6213
Volume :: 16
Issue :: 11
Database :: MEDLINE
Journal :: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Publication Type :: Academic Journal
Accession number :: 32515738
Full Text :: https://doi.org/10.4244/EIJ-D-20-00024

Full Text Access

Tools